Viewing nowPradicap 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

MFDS item code 201109152 · Approved 2011.10.25 · Insurance code 697100220
Relief of peripheral and central neuropathic pain, adjunctive therapy for partial seizures in epilepsy, treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. It also serves as an adjunctive therapy for partial seizures in epilepsy patients, effective regardless of the presence of secondary generalized symptoms. Additionally, it helps relieve pain in fibromyalgia patients. By acting safely and effectively on various neurological disorders and pain symptoms, it improves the quality of life of patients.
This medication, as pregabalin, is to be taken orally in divided doses twice daily regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose can be 150 mg daily, which may be increased to 300 mg daily within 3-7 days, and possibly to a maximum of 600 mg daily at 7-day intervals if necessary. - Central neuropathic pain: Starting dose can be 150 mg daily, which may be increased to 300 mg daily after one week.
Use is not recommended for children under 12 years of age and adolescents aged 12-17 due to insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or depressive symptoms occur during treatment, notify healthcare professionals immediately. Do not take this medication if you have had hypersensitivity reactions to it or have certain genetic disorders like lactose intolerance. Diabetic patients should be cautious as weight gain may necessitate adjustments in blood sugar control medication doses. If symptoms of angioedema occur, such as swelling of the face or around the mouth, discontinue use immediately. Elderly patients should be particularly careful during initial treatment due to the increased risk of accidents from dizziness or drowsiness. Transient blurred vision or changes in vision may occur; these symptoms may improve upon discontinuation of the medication. Discontinuing the medication suddenly may lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it should be tapered off gradually in consultation with a healthcare provider. This medication has a risk of misuse, so patients with a history of drug abuse should be particularly cautious and monitored for misuse or dependency symptoms during treatment. Patients with impaired kidney function may require dose adjustments. Patients with heart disease should use this medication with caution, as it may worsen symptoms of heart failure. Taking this medication in combination with opioid analgesics may increase the central nervous system depressant effects, posing a risk for respiratory depression. Pregnant women should avoid this medication during the early stages of pregnancy due to an increased risk of congenital malformations in the fetus, and women of childbearing age should use effective contraception. Breastfeeding women should avoid nursing while taking this medication, as it may be excreted in breast milk and affect the infant. Dangerous activities such as driving or operating machinery should be avoided until drowsiness or dizziness resolves after taking this medication. This medication may rarely cause serious skin reactions, so if any unusual symptoms such as rash or swelling occur, stop taking it immediately and consult a healthcare professional. In the case of overdose, symptoms such as confusion, drowsiness, and depression may occur, and immediate medical attention is required where blood dialysis may be necessary.
Hives, severe swelling, angioedema, facial swelling, perioral swelling, upper airway swelling, severe allergic reaction, chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mouth/eyes mucosa, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory issues accompanied by cough and fever, skin or eye jaundice
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. A temperature range of 15 to 30 degrees Celsius is recommended to maintain the medication's efficacy and safety.
Hard capsule with a brownish-red upper and a white lower, containing white powder
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.